New anticancer antibiotics under development and clinical evaluation in the National Cancer Institute.
D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis / Q000627:therapeutic use; D005285:Fermentation; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology; D009316:National Institutes of Health (U.S.); D010455:Peptides / Q000494:pharmacology; D010879:Piperazines / Q000627:therapeutic use; D011090:Polyenes / Q000494:pharmacology; D012263:Ribonucleosides; D014255:Trichothecenes / Q000494:pharmacology; D014481:United States
D000903:Antibiotics, Antineoplastic; D007555:Isoxazoles; D010455:Peptides; D010879:Piperazines; D011090:Polyenes; D012263:Ribonucleosides; D014255:Trichothecenes; D005998:Glycine